Ketotifen and chronic urticaria.
Taşkapan
O
O
Harmanyeri
Y
Y
D018926:Anti-Allergic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000982:Antipruritics / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001327:Autoimmune Diseases / Q000188:drug therapy; D002648:Child; D002908:Chronic Disease; D006634:Histamine H1 Antagonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007665:Ketotifen / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D012894:Sleep Stages / Q000187:drug effects; D013967:Thyroiditis, Autoimmune / Q000150:complications; D014581:Urticaria / Q000150:complications / Q000188:drug therapy* / Q000276:immunology
D018926:Anti-Allergic Agents; D000982:Antipruritics; D006634:Histamine H1 Antagonists; D007166:Immunosuppressive Agents; D007665:Ketotifen